ESTIMATION OF NITRIC OXIDE SYNTHASE EXPRESSION LEVEL IN DISTINGUISHING PSORIASIS FROM ATOPIC DERMATITIS AND CORRELATING IT WITH DISEASE SEVERITY
Abstract
NOS2 may play a role in the distinction between psoriasis and eczema. NOS2 expression was upregulated in psoriasis compared to eczema, which means that psoriasis could be routinely differentially diagnosed with high sensitivity and specificity by measuring NOS2 expression level.
References
Aalemi A. K., Hamdard A. G. and Sobat A. S., (2022). Correlation of Psoriasis Disability Index and Psoriasis Area and Severity Index: A Study from Afghanistan. Clin. Cosmet. Investig. Dermatol., 15:559-566. doi: 10.2147/CCID.S363343.
Abeyakirthi S., Mowbray M., Bredenkamp N., van Overloop L., Declercq L., Davis P. J., Matsui M. S. and Weller R. B., (2010). Arginase is overactive in psoriatic skin. Br. J., 163(1):193-6. doi: 10.1111/j.1365-2133.2010.09766.x
Abo-Zaid G., Sharpe R. A., Fleming L. E. , Depledge M. and Osborne N. J., (2018). Association of Infant Eczema with Childhood and Adult Asthma: Analysis of Data from the 1958 Birth Cohort Study. Int J. Environ. Res. Public Health. Jul 5; 15(7):1415. doi: 10.3390/ijerph15071415
Albert L., Lehninger. Biochemistry, The Molecular Basis Of Cell Structure And Function: Second Edition, (1975). Worth Publishers, Inc., New York. Pp. 1104.
Armstrong A. W., Mehta M. D., Schupp C. W., Gondo G. C., Bell S. J. and Griffiths C. E. M., (2021). Psoriasis prevalence in adults in the United States. JAMA Dermatol; 157:940-946.
Arnedo-Pena A., Puig-Barberà J., Artero- Civera A., Romeu-Garcia M. A., Meseguer-Ferrer N., Fenollosa- Amposta C. and Bellido-Blasco J. B., (2020). Atopic dermatitis incidence and risk factors in young adults in Castellon (Spain): A pro- spective cohort study. Allergologia et Immunopathologia., 48:(6) 694-700. doi: 10.1016/j.aller.2020.01.004
Bang C. H., Yoon J. W., Ryu J. Y., Chun J. H., Han J. H., Lee Y. B., Lee J. Y., Park Y. M., Lee S. J. and Lee J. H., (2021). Automated severity scoring of atopic dermatitis patients by a deep neural network. Sci. Rep., 11:6049. doi: 10.1038/s41598-021-85489-8. Erratum in: Sci Rep. Jul 27; 11(1):15640.
Bentz P., Eyerich K., Weber K., Kluge L., Ofenloch R. and Weisshaar E., (2021). Cohort study for long-term follow-up of patients in whom the so-called “molecular classifier” is used to distinguish eczema from psoriasis: Background and implementation. Hautarzt, 72(4), 354-357. doi: 10.1007/s00105-021-04774-9
Bozek A., Zajac M. and Krupka M., (2020). Atopic Dermatitis and Psoriasis as Overlapping Syndromes. Mediators of Inflammation, vol (2020), p:1-4. doi: 10.1155/2020/7527859
Cassano D. N., Bellia G. and Vena G. A., (2014). Gender medicine and psoriasis. World J. Dermatol; 3(3): 36-44 Available from:URL: http://www.wjgnet.com/2218-6190/full/v3/i3/36.htm DOI: http://dx.doi.org/10.5314/wjd.v3.i3.36
Chen W. Y., Chen S-C, Hsu S-Y, Lin Y- A, Shih C-M, Huang C-Y, Wang K-H, and Lee A-W (2022). Annoying Psoriasis and Atopic Dermatitis: A Narrative Review. International Journal of Molecular Sciences,23(9): 4898. https://doi.org/10.3390/ijms23094898
de Lusignan S., Alexander H., Broderick C., Dennis J., McGovern A., Feeney C. and Flohr C., (2021). The epidemiology of eczema in children and adults in England: A population-based study using primary care data. Clin. Exp. Allergy. Mar 51(3): 471-482. doi 10.1111/cea.13784
Egeberg A., Skov L., Gislason G. H., Thyssen J. P. and Mallbris L., (2017). Incidence and prevalence of psoriasis in Denmark. Acta Derm. Venereol, 97: 808-812.
Eyerich S., Onken A. T., Weidinger S., Franke A., Nasorri F., Pennino D., Grosber M., Pfab F., Schmidt- Weber C. B., Mempel M., Hein R., Ring J., Cavani A. and Eyerich K., (2011). Mutual antagonism of T cells causing psoriasis and atopic eczema. N. Engl. J. Med.July 21, 365(3):231-238. doi: 10.1056/NEJMoa1104200
Fan R. and Cohen J. M., (2022). Vaccination Recommendations for Psoriasis and Atopic Dermatitis Patients on Biologic Therapy: A Practical Guide. Yale J. Biol. Med., 30 95 (2):249-255.
Farhat Y., (2012). “Measuring RNA Yield with a NanoDrop Spectrophotometer.” The Protocol Place. http://protocol-place.com
Felix F., Roenneberg S., Graner L., Franziska S., Zengerle R., Fabian J. T., Carsten B., Schmidt-Weber, Biedermann T., Lauffer F., Garzorz-Stark N. and Eyerich S., (2022). Gene expression-based molecular test proves clinical validity as diagnostic aid for the differential diagnosis of psoriasis and eczema in formalin-fixed and paraffin-embedded tissue. BM. J. Yale 05.18.22275097. https://doi.org/10.1101/2022.05.18.22275097
Flohr C. and Hay R., (2021). Putting the burden of skin diseases on the global map. Br. J. Dermatol., 184: 189-190. https://doi.org/10.1111/bjd.19704
Garzorz-Stark N., Krause L., Lauffer F., Atenhan A., Thomas J., Stark S. P., Franz R., Weidinger S., Balato A., Mueller N. S., Theis F. J., Ring J., Schmidt-Weber C. B., Biedermann T., Eyerich S. and Eyerich K., (2016). A novel molecular disease classifier for psoriasis and eczema. Exp. Dermatol, 25(10):767- 774. doi: 10.1111/exd.13077
Guillet C., Corsin S., Meienberger N., Maul, L. V. and Maul Julia-Tatjana, (2022). The impact of gender and sex in psoriasis: What to be aware of when treating women with psoriasis. International Journal of Women’s Dermatology: June 8; 2:p e010 doi: 10.1097/JW9.0000000000000010
Guttman-Yassky E., Krueger J. G. and Lebwohl M. G., (2018). Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment. Exp. Dermatol, 27: 409-417.
Hay R. J., Augustin M., Griffiths C. E. M. and Sterry W., (2015). The global challenge for skin health. Br. J. Dermatol, 172: 1469-1472.
Kadam D. P., Suryakar A. N., Ankush R. D. and Kadam C. Y., (2010). Role of oxidative stress in various stages of psoriasis. Indian. J. Clin. Biochem., 25:388-392.
Karimkhani C., Dellavalle R. P., Coffeng L. E., Flohr C., Hay R. J., Langan S. M., Nsoesie E. O., Ferrari A. J., Erskine H. E., Silverberg J. I., Vos T. and Naghavi M., (2017). Global Skin Disease Morbidity and Mortality: An Update From the Global Burden of Disease Study, 2013. JAMA Dermatol, 153(5):406-412. doi: 10.1001/jamadermatol.2016.5538
Kilby BA. Biochemistry & Molecular Biology (1976). Volume 4, Issue 3 July Pages 61-61.
Livak K. J. and Schmittgen T. D., (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) Method. Methods, 25(4):402-8. doi: 10.1006/meth.2001.1262
Mahmoud A., Abo-Elmaged R., Fahmy
H. and Nada H., (2013). Estimation of nitric oxide level in psoriatic patients and its correlation with disease severity. Egypt J. Dermatol Venerol, 33:71-75.
Megna M. and Fabbrocini G., (2020). Psoriasis and atopic dermatitis: different entities with unsolved challenges. Br. J. Dermatol, 183: 12-12. https://doi.org/10.1111/bjd.18789
Napolitano M., Megna M., Fabbrocini G., Nisticò S. P., Balato N., Dastoli S. and Patruno C., (2019). Eczematous eruption during anti-interleukin 17 treatment of psoriasis: an emerging condition. Br. J. Dermatol, 181(3):604-606. doi: 10.1111/bjd.17779
Natalie G. and Kilian E., (2015). NOS2 and CCL27: clinical implications for psoriasis and eczema diagnosis and management, Expert Review of Clinical Immunology, 11(2): 167-169. doi: 10.1586/1744666X.2015.996549
Nomura I., Gao B., Boguniewicz M., Darst M. A., Travers JB. and Leung D. Y., (2003). Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J. Allergy Clin. Immunol., 112(6):1195-11202.doi: 10.1016/j.jaci.2003.08.049
Patruno C., Fabio A, Zagaria O. and Bala- to N., (2014). Is Cigarette Smoking Dangerous for Chronic Hand Eczema in Housewives? Dermatitis: July/August 25(4): 201-204. doi: 10.1097/DER.0000000000000054
Quaranta M., Knapp B., Garzorz N., Mattii M., Pullabhatla V., Pennino D. and Eyerich K., (2014). Intraindividual genome expression analysis reveals a specific molecular signature of psoriasis and eczema. Sci. Transl Med, 6(244), 244ra290. doi: 10.1126/scitranslmed.3008946
Saunes M., Øien T., Storrø O. and John- sen R., (2011). Family eczema- history in 2-year-olds with eczema; a prospective, population-based study. The PACT-study, Norway. BMC Dermatol., 11:11. doi: 10.1186/1471-5945-11-11
Solmaz D., Bakirci S., Kimyon G., Gunal E. K., Dogru A., Bayindir O., Dalkilic E., Ozisler C., Can M., Akar S., Cetin G. Y., Yavuz S., Kilic L., Tarhan E. F., Kucuksahin O., Omma A., Gonullu E., Yildiz F., Ersozlu E. D., Cinar M., Al- Onazi A., Erden A., Tufan M. A., Yilmaz S., Pehlevan S., Kalyoncu U. and Aydin S. Z., (2020). Impact of Having Family History of Psoriasis or Psoriatic Arthritis on Psoriatic Disease. Arthritis Care Res. (Hoboken), 72 (1):63-68. doi: 10.1002/acr.23836
Tsai T. F., Wang T. S., Hung S. T., Tsai P. I., Schenkel B., Zhang M. and Tang C. H., (2011). Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan. J. Dermatol. Sci., 63(1):40-46.doi: 10.1016/j.jdermsci.2011.03.002
Vaccaro M., Irrera N., Cutroneo G., Rizzo G., Vaccaro F., Anastasi G. P., Borgia F., Cannavò S. P., Altavilla D. and Squadrito F., (2017). Differential Expression of Nitric Oxide Synthase Isoforms nNOS and iNOS in Patients with Non-Segmental Generalized Vitiligo. Int. J. Mol. Sci., 18: 2533. https://doi.org/10.3390/ijms18122533
Wei L., Chen S., Zhang Z., Kuai L., Zhang R., Yu N., Shi Y., Li B. and Wang R., (2022). Prevalence of Tobacco Smoking and Its Association With Disease Severity Among Patients With Psoriasis in China: A Cross-Sectional Study. Front. Med. 9:883458. doi: 10.3389/fmed.2022.883458
Yamamah G. A., Emam H. M., Abdelhamid M. F., Elsaie M. L., Shehata H., Farid T., Kamel M. I. and Taalat A. A., (2012). Epidemiologic study of dermatologic disorders among children in South Sinai, Egypt. Inter. J. of Dermatology, 51:1180-1185.
